Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

How Medicare will cover Aduhelm, the controversial Alzheimer’s drug – Advisory Board,

Background. Biogen received conditional FDA approval for Aduhelm last June, after a company analysis of clinical trial data found that a high dose of …, Background. Biogen received conditional FDA approval for Aduhelm last June, after a company analysis of clinical trial data found that a high dose of …, Read More

Scroll to Top